Tumor Immunotherapy

  • P. Koldovsky
Conference paper


In 1951, when I started to study medicine at the Karlova Universita (Charles University) in Prague, I was interested in working at the Institute of General Biology. An older, politically powerful student manipulated me into the department of “aspirants.” These aspirants were so called because they hoped to become Candidate of Science (corresponding to a PhD). The department was headed by a young man fresh from medical school — Milan Hašek. His wife Vera, Marta Vojtiskova, and Jan Grozdanovic also belonged to the group. The technicians were Ludek Martinek and Eva Linkova. One year later Tomas Hraba came, and the following year Jan Hort joined the group.


Autologous Tumor Lymphokine Activate Killer Renal Capsule Lymphokine Activate Killer Cell Tumor Immunotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bogden AE, Haskell PM, Le Page DJ, Kelton DE, Cobb WR, Ester HK (1979) Growth of human tumor xenografts implanted under the renal capsule of normal immunocompetent mice. Exp Cell Biol 47: 281–293PubMedGoogle Scholar
  2. Bubenik J, Koldovsky P (1964) The mechanismus of anti-tumor immunity studied by means of transfer of immunity. Folia Biol (Praha) 10: 427–441Google Scholar
  3. Coates AS, Crawford M (1977) Growth of human melanoma in nude mice: suppression by T-lymphocytes from the tumor donor. J Natl Cancer Inst 59: 1325–1329PubMedGoogle Scholar
  4. Grimm EA, Wilson DJ (1985) The human lymphokine activated killer system. Cell Immunol 94: 568–578PubMedCrossRefGoogle Scholar
  5. Héricourt J, Richet C (1895) Remarques à propos de la note de M. Boureau sur la sérothérapie des néoplasma. C R Seances Acad Sci 21: 273–281Google Scholar
  6. Kau R, Kárten C, Kumazawa H, Koldovsky P (1989) Antibody dependent cellular cytotoxicity against tumors of the head and neck region measured by subrenal capsule assay. Arch Otorhinolaryngol (in press)Google Scholar
  7. Koldovsky P, Weinstein J (1973) Expression of non-tumor-specific antigens in human tumor cells. Natl Cancer Inst Monogr 37: 33–35PubMedGoogle Scholar
  8. Koldovsky P, Koldovsky U, Beck L, Vosteen KH (eds) (1989) Lymphocytes in cancer therapy. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  9. Peri G, Zanaboni F, Rossini S, Mangioni C, Landoni F, Epis A, Mantovani A (1986) Evaluation of the interaction of mononuclear phagocytes with ovarian carcinoma cells in a colony assay. Br J Cancer 53: 47–52PubMedCrossRefGoogle Scholar
  10. Prehn RT (1977) Immunostimulation of the lymphdependent phase of neoplastic growth. J Natl Cancer Inst 59: 1043PubMedGoogle Scholar
  11. Ritz J, Schlossman SF (1982) Utilisation of monoclonal antibodies in the treatment of leukemia and lymphoma. Blood 59: 1–11PubMedGoogle Scholar
  12. Vose BM (1984) Activation of lymphocytes antitumor responses in man. Cancer Immunol Immunother 17: 73–75PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • P. Koldovsky

There are no affiliations available

Personalised recommendations